Each tumor-focused program agenda is comprised of multidisciplinary, case-based presentations that will break down the most clinically relevant information applicable to community care. These dinner programs will be hosted as an in-person events only.

LEARNING OBJECTIVES

• Employ an understanding of personalized medicine to individualize the use of available drugs for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies.
• Communicate the efficacy and safety of the drugs discussed in the case studies and other emerging treatments for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies.
• Understand the emerging and standard diagnostic tests used to assist in planning therapy for lung cancers, gastrointestinal cancers, breast cancers, genitourinary cancers, and hematological malignancies.
• Formulate management strategies, considering the contributory roles of local and systemic therapy.
• Recall the design of ongoing clinical trials evaluating novel investigational agents and counsel appropriately selected patients about availability and participation.

ACCREDITATION

Amedco LLC designates this live activity for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

For more information please visit the official event page.